Venture Certified
| 연구개발유형 | 2020-07-30 ~ 2022-07-29 | 20200401778 | 2020-07-30 |
| 연구개발유형 | 2022-07-30 ~ 2025-07-29 | 20220803020039 | 2020-07-30 |
| 연구개발유형 | 2025-07-30 ~ 2028-07-29 | 20250702020028 | 2020-07-30 |
Revenue CAGR +43.4%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 3.7B | 2.4B | 1.8B |
| Operating Profit | -0.1B | -2.8B | -1.3B |
| Net Profit | 2.6B | 1.8B | 1.2B |
| Total Assets | 12.4B | 4.7B | 3.3B |
| Total Liabilities | 8.2B | 3.1B | 3.5B |
| Total Equity | 4.2B | 1.6B | -0.2B |
Operating Loss: Op. profit -60510K
▲ 76.8%
▲ 97.0%
▲ 98.3%
▲ 130.2%
▲ 132.0%
| Name | Position | Role |
|---|---|---|
| 서우영 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 수원시",
"ceo_name": "서우영",
"certificate": [
{
"cert_number": "20200401778",
"changes": "",
"disclosure_date": "2020-07-30",
"first_cert_date": "2020-07-30",
"no": "1",
"type": "연구개발유형",
"valid_period": "2020-07-30 ~ 2022-07-29"
},
{
"cert_number": "20220803020039",
"changes": "",
"disclosure_date": "2022-08-03",
"first_cert_date": "2020-07-30",
"no": "2",
"type": "연구개발유형",
"valid_period": "2022-07-30 ~ 2025-07-29"
},
{
"cert_number": "20250702020028",
"changes": "",
"disclosure_date": "2025-07-02",
"first_cert_date": "2020-07-30",
"no": "3",
"type": "연구개발유형",
"valid_period": "2025-07-30 ~ 2028-07-29"
}
],
"company_name": "(주)에이바이오테크",
"corp_no": "135811-*******",
"financials": {
"2022": {
"capital_stock": 56155000,
"cost_of_sales": 0,
"current_assets": 41180000,
"current_liabilities": 51063000,
"gross_profit": 179188000,
"net_income": 119456000,
"net_income_bs": 119457000,
"non_current_assets": 286383000,
"non_current_liabilities": 300000000,
"non_operating_expenses": 10358000,
"non_operating_income": 259855000,
"operating_profit": -130041000,
"revenue": 179188000,
"sga_expenses": 309229000,
"total_assets": 327563000,
"total_equity": -23500000,
"total_liabilities": 351063000
},
"2023": {
"capital_stock": 56155000,
"cost_of_sales": 0,
"current_assets": 73363000,
"current_liabilities": 39565000,
"gross_profit": 237784000,
"net_income": 179048000,
"net_income_bs": 179049000,
"non_current_assets": 391663000,
"non_current_liabilities": 269911000,
"non_operating_expenses": 13884000,
"non_operating_income": 469142000,
"operating_profit": -276210000,
"revenue": 237784000,
"sga_expenses": 513994000,
"total_assets": 465026000,
"total_equity": 155549000,
"total_liabilities": 309477000
},
"2024": {
"capital_stock": 56155000,
"cost_of_sales": 0,
"current_assets": 777567000,
"current_liabilities": 55020000,
"gross_profit": 368651000,
"net_income": 262880000,
"net_income_bs": 262880000,
"non_current_assets": 457767000,
"non_current_liabilities": 761885000,
"non_operating_expenses": 12047000,
"non_operating_income": 280977000,
"operating_profit": -6050000,
"revenue": 368651000,
"sga_expenses": 374702000,
"total_assets": 1235333000,
"total_equity": 418429000,
"total_liabilities": 816905000
}
},
"industry": "기타 공학 연구개발업",
"investment": [],
"main_products": "생명공학기술,제품,바이오용품 연구개발/화장품원료,화장품,화장용품,바이오용품,생명공학제품 도소매",
"phone": "031-5186-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |